National AIDS Trust - Pre-Exposure Prophylaxis

14 April 2016 by Pure Radio

Pre-Exposure Prophylaxis, or Prep for short, is a drug that, if taken daily, can reduce the risk of acquiring HIV.

A number of studies around the world, have shown that it’s very effective at preventing the transmission of the virus.

The Senior Policy and Campaigns Manager at the National AIDS Trust, Sarah Radcliffe, has been telling Under the Rainbow about the latest developments.

Download MP3 (8 MB | 5:51 min)



Dec 2015 - Freedom To Donate

3 December 2015 by Pure Radio

Blood donations help save many lives every year. Although over the past decade, donations have reduced by more than a third.

Current regulations restrict gay and bisexual men from giving blood.

Under the Rainbow has been chatting with Ethan Spibey, the founder of Freedom to Donate – who are campaigning for a change in the law.

Download MP3 (6 MB | 4:01 min)



Question Time, Spending Review and Flu 1 Dec 15

1 December 2015 by Pure Radio

Local mother Sally Wheatman’s interrogation of Conservative minister Matthew Hancock on BBC Question Time went viral this week — Sally joins us to talk about the experience. Plus the impact of the Autumn Statement on people with special needs, and with GPs reporting they’ve given out fewer flu jabs this year than in the past, we find out who should get one.

Download MP3 (31 MB | 34:17 min)



Nov 2015 - PrEPster.info

12 November 2015 by Pure Radio

Pre-Exposure Prophylaxis is a treatment that has shown promise in preventing negative people from acquiring HIV.

After recent successful trials, the NHS is due to announce a decision on it’s availability in April.

PrEPster.info is a website that aims to provide more information and advocate for the treatment’s availability.

Under the Rainbow has been speaking to Marc Thompson, who is co-founder of the site.

Download MP3 (8 MB | 6:00 min)



Oct 2015 - Pre-Exposure Prophylaxis

1 October 2015 by Pure Radio

Last week they heard about the PROUD study, which looked into the effectiveness of Pre-Exposure Prophylaxis. The research showed that the drug can significantly reduce the likelihood of HIV infections.

Tonight, Under the Rainbow will hear more from Michael Brady, who is the Principal Clinical Investigator of the study at Kings College Hospital in London.

Download MP3 (10 MB | 7:30 min)



   Next page >>